The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance).
 
Jeffrey Melson Clarke
No Relationships to Disclose
 
Herbert Pang
No Relationships to Disclose
 
Mark D. Starr
No Relationships to Disclose
 
Ace Joseph Hatch
No Relationships to Disclose
 
Hedy Lee Kindler
Consulting or Advisory Role - Genentech
Research Funding - Genentech
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Aduro Biotech; Astellas Pharma (I); Celgene; Celsion (I); Cipla; Exelixis (I); Hexal (I); IntegraGen (I); Jennerex (I); Lilly (I); MedImmune; Novartis (I); Pharmacyclics; Sanofi; Silenseed; Vicus Therapeutics (I)
Research Funding - Clovis Oncology (Inst); Immunomedics (Inst); Incyte (Inst); Momenta Pharmaceuticals (Inst); Myriad Genetics (Inst); OncoMed (Inst)
 
Federico Innocenti
No Relationships to Disclose
 
Alan P. Venook
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Onyx (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Halozyme; Roche
 
Herbert Hurwitz
Honoraria - Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Acceleron Pharma; Amgen; Bayer; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; Regeneron; Sanofi; TRACON Pharma
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); TRACON Pharma (Inst)
 
Andrew B. Nixon
Consulting or Advisory Role - GlaxoSmithKline; Novartis
Research Funding - Amgen; Pfizer; Proacta; TRACON Pharma